PlumX Metrics
Embed PlumX Metrics

Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy

Mediators of Inflammation, ISSN: 0962-9351, Vol: 2012, Page: 629452
2012
  • 73
    Citations
  • 21
    Usage
  • 150
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Anatomical and Functional Outcomes of Use of Methotrexate Infusion and Intrasilicone Injection During Diabetic Vitrectomy

2023 OCT 04 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Daily -- Staff editors report on the newly launched clinical trial,

Review Description

The global prevalence of diabetes is estimated to be 336 million people, with diabetic complications contributing to significant worldwide morbidity and mortality. Diabetic retinopathy results from cumulative microvascular damage to the retina and inflammation is recognized as a critical driver of this disease process. This paper outlines the pathophysiology leading to proliferative diabetic retinopathy and highlights many of the inflammatory, angiogenic, and cytokine mediators implicated in the development and progression of this disease. We focus a detailed discussion on the current targeted therapeutic interventions used to treat diabetic retinopathy. © 2012 Daniel Gologorsky et al.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know